ALLOPURINOL
Active substance: allopurinol
TABLET · ALLOPURINOL 300 mg/1
United StatesActive
Marketing holder: XLCare Pharmaceuticals Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
Composition
- ALLOPURINOL · 300 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 18 |
|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2727-7735-bb54-938c11e55daa,01a1208c-41ca-7063-92db-1fd7ef58fde6,01a1208c-41cb-72bf-8ebb-df26dad8704a,01a1208c-4a95-7e7f-8717-94706272610b,01a1208c-646b-7aed-a2ff-01321ba3e835;count=171 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 72865-304
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 72865-304 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 72865-304 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 72865-304 · Verified 2026-10-09 · open in source